Total Payments
$94,777
2024 Payments
$5,737
Companies
47
Transactions
789
Medicare Patients
10,178
Medicare Billing
$819,126
Payment Breakdown by Category
Other$55,460 (58.5%)
Food & Beverage$20,261 (21.4%)
Research$11,926 (12.6%)
Consulting$3,575 (3.8%)
Travel$3,361 (3.5%)
Education$193.34 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $55,460 | 30 | 58.5% |
| Food and Beverage | $20,261 | 726 | 21.4% |
| Unspecified | $11,926 | 4 | 12.6% |
| Consulting Fee | $3,575 | 4 | 3.8% |
| Travel and Lodging | $3,361 | 18 | 3.5% |
| Education | $193.34 | 7 | 0.2% |
Payments by Type
General
$82,851
785 transactions
Research
$11,926
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31,023 | 56 | $0 (2024) |
| Amarin Pharma Inc. | $17,655 | 20 | $0 (2022) |
| Eli Lilly and Company | $11,926 | 4 | $0 (2023) |
| Lilly USA, LLC | $10,814 | 18 | $0 (2022) |
| Abbott Laboratories | $3,935 | 62 | $0 (2024) |
| Edwards Lifesciences Corporation | $3,674 | 10 | $0 (2023) |
| Amgen Inc. | $2,339 | 161 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,435 | 55 | $0 (2024) |
| Boston Scientific Corporation | $1,402 | 18 | $0 (2024) |
| CVRx, Inc. | $1,021 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,737 | 160 | Abbott Laboratories ($1,589) |
| 2023 | $13,412 | 126 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,714) |
| 2022 | $22,993 | 99 | Eli Lilly and Company ($10,779) |
| 2021 | $9,918 | 87 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,763) |
| 2020 | $576.65 | 23 | Boston Scientific Corporation ($139.94) |
| 2019 | $38,493 | 152 | Amarin Pharma Inc. ($17,623) |
| 2018 | $1,961 | 77 | Boston Scientific Corporation ($316.54) |
| 2017 | $1,687 | 65 | Aralez Pharmaceuticals US Inc. ($324.04) |
All Payment Transactions
789 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $112.38 | General |
| Category: Structural Heart | ||||||
| 12/31/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $57.23 | General |
| Category: Structural Heart | ||||||
| 12/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $567.96 | General |
| Category: Structural Heart | ||||||
| 12/17/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Structural Heart | ||||||
| 12/13/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $38.08 | General |
| Category: Coronary | ||||||
| 12/12/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $183.57 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/12/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $27.39 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $134.63 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $36.72 | General |
| Category: Structural Heart | ||||||
| 12/11/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $32.46 | General |
| Category: Structural Heart | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Vascular | ||||||
| 12/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $38.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.20 | General |
| Category: Cardiovascular | ||||||
| 12/04/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $179.25 | General |
| Category: Structural Heart | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $351.67 | General |
| Category: Structural Heart | ||||||
| 11/26/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: Structural Heart | ||||||
| 11/26/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: Structural Heart | ||||||
| 11/26/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: Structural Heart | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.87 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: Structural Heart | ||||||
| 11/20/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/20/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $6.96 | General |
| Category: Coronary | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY (SUMMIT | Eli Lilly and Company | $11,807 | 3 |
| A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY (SUMMIT | Eli Lilly and Company | $119.68 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,586 | 3,611 | $937,965 | $269,956 |
| 2022 | 29 | 2,150 | 2,680 | $619,963 | $176,076 |
| 2021 | 30 | 2,696 | 3,293 | $597,978 | $189,839 |
| 2020 | 35 | 2,746 | 3,286 | $499,858 | $183,255 |
Total Patients
10,178
Total Services
12,870
Medicare Billing
$819,126
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 577 | 767 | $265,382 | $71,863 | 27.1% |
| G0422 | Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | Office | 2023 | 174 | 573 | $185,079 | $56,176 | 30.4% |
| G0423 | Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | Office | 2023 | 140 | 421 | $135,983 | $41,264 | 30.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 128 | 151 | $73,386 | $21,119 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 111 | 111 | $49,839 | $14,483 | 29.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 206 | 208 | $38,688 | $10,826 | 28.0% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Office | 2023 | 87 | 87 | $26,535 | $7,283 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $21,348 | $6,096 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 88 | $21,560 | $5,908 | 27.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 98 | 98 | $20,188 | $5,560 | 27.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 96 | 96 | $17,856 | $4,825 | 27.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 46 | $12,420 | $4,410 | 35.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $15,630 | $4,193 | 26.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 57 | $10,716 | $3,634 | 33.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 108 | 108 | $6,264 | $1,716 | 27.4% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 66 | 91 | $6,370 | $1,704 | 26.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 112 | 119 | $4,641 | $1,366 | 29.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 71 | 74 | $4,736 | $1,354 | 28.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 120 | 120 | $4,680 | $1,268 | 27.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 12 | 13 | $3,731 | $1,024 | 27.4% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 60 | 112 | $3,472 | $928.62 | 26.7% |
| 0504T | Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | Office | 2023 | 14 | 14 | $1,036 | $745.81 | 72.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 24 | 25 | $2,275 | $607.86 | 26.7% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 29 | 29 | $1,914 | $543.48 | 28.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 49 | 57 | $1,672 | $365.94 | 21.9% |
About Dr. Grant Bailey, M.D
Dr. Grant Bailey, M.D is a Internal Medicine healthcare provider based in Littleton, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2010. The National Provider Identifier (NPI) number assigned to this provider is 1881919660.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Grant Bailey, M.D has received a total of $94,777 in payments from pharmaceutical and medical device companies, with $5,737 received in 2024. These payments were reported across 789 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($55,460).
As a Medicare-enrolled provider, Bailey has provided services to 10,178 Medicare beneficiaries, totaling 12,870 services with total Medicare billing of $819,126. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Cardiovascular Disease
- Location Littleton, CO
- Active Since 04/05/2010
- Last Updated 08/09/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881919660
Products in Payments
- JARDIANCE (Drug) $41,715
- Vascepa (Drug) $17,655
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $2,466
- Mitra Clip system (Device) $1,771
- Repatha (Biological) $1,576
- ENTRESTO (Drug) $1,088
- Barostim Neo System (Device) $1,021
- FFRct (Device) $830.05
- LifeVest (Device) $817.60
- ELIQUIS (Drug) $617.36
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $549.38
- XARELTO (Drug) $541.59
- CAMZYOS (Drug) $512.43
- Corlanor (Drug) $468.69
- LEQVIO (Drug) $346.93
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $343.92
- NEXLETOL (Drug) $311.02
- WATCHMAN Access System (Device) $294.59
- FARXIGA (Drug) $292.00
- ZONTIVITY (Drug) $281.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Littleton
Dr. Manojkumar Bupathi, M.d, M.D
Internal Medicine — Payments: $350,668
Internal Medicine $350,668
Dr. Joshua Portnoy, M.d, M.D
Internal Medicine — Payments: $38,564
Internal Medicine $38,564
Dr. Sophia Ambruso, D.o, D.O
Internal Medicine — Payments: $37,607
Internal Medicine $37,607
Dr. Erin Riggle, M.d, M.D
Internal Medicine — Payments: $24,991
Internal Medicine $24,991
Dr. Celinde Strohl, Md, MD
Internal Medicine — Payments: $17,389
Internal Medicine $17,389
Kelly Greene, M.d, M.D
Internal Medicine — Payments: $16,955
Internal Medicine $16,955